Antibiotics MDPI

29/04/2026

💊New published

Routine Susceptibility Testing of Helicobacter pylori in Clinical Practice—Results of a Prospective Multicentre Study

🖊️by Anke Hildebrandt et al. from University Hospital Münster

👉Full paper: https://www.mdpi.com/2079-6382/15/5/426

29/04/2026

💊New published

When Hours Matter: A 24/7 Laboratory and Fast-Track Diagnostic Pathway for Blood Cultures in Critical Patients

🖊️by Marta Corbella et al. from Fondazione IRCCS Policlinico San Matteo

👉Full paper: https://www.mdpi.com/2079-6382/15/5/425

27/04/2026

💊New published

Emerging Filamentous Basidiomycetes as Opportunistic Human Pathogens: Diagnostic and Antifungal Challenges in a Tertiary-Care Center in Thailand

🖊️by Chaianant Leelabooranasak et al. from Chulalongkorn University

👉Full paper: https://www.mdpi.com/2079-6382/15/5/424 #

24/04/2026

💊New published

Prescribing Patterns and Clinical Effectiveness of Ceftolozane/Tazobactam for ESBL-Producing Enterobacterales: A SPECTRA Real-World Multi-Country Analysis

🖊️by Emre Yucel et al. from Merck & Co.

👉Full paper: https://www.mdpi.com/2079-6382/15/5/423

24/04/2026

💊New published

Safety Profiles of Polymyxins, Aminoglycosides, and Imipenem/Cilastatin/Relebactam (IMI/REL) in the Treatment of Gram-Negative Infections: A Literature Review

🖊️by Hannah Collings et al. from Adelphi Values PROVE

👉Full paper: https://www.mdpi.com/2079-6382/15/5/422 #

23/04/2026

📢 We are delighted to announce that Prof. Dr. Ting Han from National Institute of Biological Sciences, Beijing, China, will serve as a keynote speaker for the 5th Medicinal Chemistry Symposium ( 2026): New Trends in Chemical Biology and Drug Discovery, which will be held in , China, from May 14 to 17, 2026.

✨ Don't miss the opportunity to interact with Prof. Dr. Ting Han!
🔗 Secure your spot: https://brnw.ch/21x1P5n
📅 Conference program: https://brnw.ch/21x1P5p

📢 We are delighted to announce that Prof. Dr. Ting Han from National Institute of Biological Sciences, Beijing, China, will serve as a keynote speaker for the 5th Medicinal Chemistry Symposium ( 2026): New Trends in Chemical Biology and Drug Discovery, which will be held in , China, from May 14 to 17, 2026.

🎤 Prof. Dr. Ting Han is an Associate Investigator at the National Institute of Biological Sciences. His laboratory focuses on two complementary fields—chemical biology and cancer biology—with the convergence point being the development of innovative cancer therapeutic strategies. Their goal is to address two major challenges in biomedical research: (1) the lack of general methods to effectively modulate most disease-causing proteins, and (2) the diminishing availability of new targets to support future therapeutic innovation. Over the past several years, they have made progress in these areas through two approaches: "chemistry-driven" and "biology-driven". These studies have not only deepened the understanding of cancer biology but also provided new targets and chemical starting points for the development of anticancer therapies.

✨ Don't miss the opportunity to interact with Prof. Dr. Ting Han!
🔗 Secure your spot: https://brnw.ch/21x1P5n
📅 Conference program: https://brnw.ch/21x1P5p

17/04/2026

🤝 Join the 5th Molecules Medicinal Chemistry Symposium (MMCS2026) as a Sponsor! Position your brand at the forefront of global cutting-edge research in chemical biology and drug discovery.

📍 Location: Beijing, China
🗓️ Date: 14–17 May 2026

📢 Limited Opportunities Remaining: We currently have only 3 booth packages left, along with a variety of tailored individual sponsorship benefits.

🌟 Why Sponsor MMCS2026?
Connect with distinguished researchers and elite R&D teams from more than 100 prestigious universities and institutions. Whether you provide lab instruments, drug R&D services, or specialized reagents, this is your platform to:
• Showcase products at high-visibility booths.
• Engage with experts through dedicated speaking slots.
• Enhance brand recognition via our global promotion network (web, print, and on-site engagement).
• Network with inclusive registration slots for your team.

👉 Explore full details here: https://brnw.ch/21x1rZm

🤝 Join the 5th Molecules Medicinal Chemistry Symposium (MMCS2026) as a Sponsor! Position your brand at the forefront of global cutting-edge research in chemical biology and drug discovery.

📍 Location: Beijing, China
🗓️ Date: 14–17 May 2026

📢 Limited Opportunities Remaining: We currently have only 3 booth packages left, along with a variety of tailored individual sponsorship benefits.

🌟 Why Sponsor MMCS2026?
Connect with distinguished researchers and elite R&D teams from more than 100 prestigious universities and institutions. Whether you provide lab instruments, drug R&D services, or specialized reagents, this is your platform to:
• Showcase products at high-visibility booths.
• Engage with experts through dedicated speaking slots.
• Enhance brand recognition via our global promotion network (web, print, and on-site engagement).
• Network with inclusive registration slots for your team.

👉 Explore full details here: https://brnw.ch/21x1rZm

📩 Contact us: [email protected]

03/04/2026

📢 We are delighted to announce that Prof. Dr. Huilei Yu from East China University of Science and Technology, China, will serve as a Scientific Committee Member for the 5th Medicinal Chemistry Symposium ( ): New Trends in Chemical Biology and Drug Discovery, which will be held in , China, from May 14 to 17, 2026.

📝 Late-breaking Poster Submissions Still Open: https://brnw.ch/21x1hXx

📢 We are delighted to announce that Prof. Dr. Huilei Yu from East China University of Science and Technology, China, will serve as a Scientific Committee Member for the 5th Medicinal Chemistry Symposium ( ): New Trends in Chemical Biology and Drug Discovery, which will be held in , China, from May 14 to 17, 2026.

🎓 Professor Yu is a professor and doctoral supervisor at East China University of Science and Technology. Her research focuses on the discovery, design, and applied fundamentals of novel enzymes. Centering on the key scientific issue of "enzyme structure–function relationships and their regulatory mechanisms," she has established enzyme molecular design strategies based on computational modeling and deep learning, achieving "functional reprogramming" through large-scale cooperative mutations in enzyme active centers and "directed evolution" for industrial applicability. She has also proposed substrate-targeted rational enzyme design strategies and developed non-natural enzyme molecular tools such as taxane site-specific oxidation enzymes and asymmetric thioether oxidation enzymes. She has published over 100 SCI-indexed papers in leading journals and holds more than 20 granted Chinese invention patents as well as 3 granted U.S. patents.

📝 Late-breaking Poster Submissions Still Open: https://brnw.ch/21x1hXx

27/03/2026

💊New published

Prescribing Patterns and Clinical Outcomes of Ceftolozane/Tazobactam by Renal Function and Body Mass Index: A SPECTRA Real-World Multi-Country Analysis

🖊️by Emre Yucel et al.

👉Full paper: https://www.mdpi.com/2079-6382/15/3/303

25/03/2026

💊New published

Goondoxazoles A–C: Anthelmintic Spiroketal Polyketide Alkaloids and Other Benzoxazoles from Australian Pasture Soil-Derived Streptomyces spp.

🖊️by Shengbin Jin et al. from The University of Queensland

👉Full paper: https://www.mdpi.com/2079-6382/15/3/302 #

25/03/2026

📢 We are delighted to announce that Dr. Albert Antolin Hernandez from Vall d’Hebron Institute of Oncology - VHIO, Barcelona, Spain, will serve as a keynote speaker for the 5th Medicinal Chemistry Symposium ( ): New Trends in Chemical Biology and Drug Discovery, which will be held in , China, from May 14 to 17, 2026.

✨ Don't miss the opportunity to interact with Dr. Antolin Hernandez!

📝 Late-breaking Poster Submissions Now Open: https://brnw.ch/21x0S88

📢 We are delighted to announce that Dr. Albert Antolin Hernandez from Vall d’Hebron Institute of Oncology - VHIO, Barcelona, Spain, will serve as a keynote speaker for the 5th Medicinal Chemistry Symposium ( ): New Trends in Chemical Biology and Drug Discovery, which will be held in , China, from May 14 to 17, 2026.

🎤 Dr. Albert Antolin Hernandez is an organist chemist (Ramon Llull University) with two years of in-silico medicinal chemistry experience in the pharma industry (Laboratorios Salvat), co-authoring an anti-diabetic patent. Holding a PhD in pharmacoinformatics from Pompeu Fabra University, he pioneered polypharmacology prediction in chemical biology. After his PhD, he secured a Marie Curie Fellowship at the Institute of Cancer Research (ICR, London) to develop Probe Miner, an objective resource for chemical probe assessment. In 2023, he received a tenure-track Miguel Servet Fellowship and joined VHIO as a Group Leader in 2025. His lab focuses on developing chemical biology resources, understanding drug mechanisms at a systems level, advancing AI for drug design, and discovering safer anti-cancer therapies. With industry and academic experience, Dr. Antolin Hernandez is dedicated to translational research bridging industrial drug discovery with cancer chemical systems biology.

✨ Don't miss the opportunity to interact with Dr. Antolin Hernandez!
📝 Late-breaking Poster Submissions Now Open: https://brnw.ch/21x0S88